ALN-AT3SC Uses, Dosage, Side Effects and more
ALN-AT3SC is under investigation in clinical trial NCT02554773 (An Open-label Extension Study of an Investigational Drug, ALN-AT3SC, in Patients With Moderate or Severe Hemophilia A or B).
| Attribute | Details |
|---|---|
| Trade Name | ALN-AT3SC |
| Generic | Fitusiran |
| Fitusiran Other Names | ALN-AT3SC, Fitusiran |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
